UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist gegebenenfalls nur via VPN oder Shibboleth (DFN-AAI) möglich. mehr Informationen...

Preoperative Chemoradiotherapy Versus Immediate Surgery for Resectable and Borderline Resectable Pancreatic Cancer: Results of the Dutch Randomized Phase III PREOPANC Trial

Journal of clinical oncology, 2020-06, Vol.38 (16), p.1763-1773

2020

Link zum Volltext

Verfügbarkeit prüfen

Neoadjuvant Chemoradiotherapy Versus Upfront Surgery for Resectable and Borderline Resectable Pancreatic Cancer: Long-Term Results of the Dutch Randomized PREOPANC Trial

Journal of clinical oncology, 2022-04, Vol.40 (11), p.1220-1230

2022

Link zum Volltext

Verfügbarkeit prüfen

Clinical activity and tolerability of enzalutamide (MDV3100) in patients with metastatic, castration‐resistant prostate cancer who progress after docetaxel and abiraterone treatment

Cancer, 2014-04, Vol.120 (7), p.968-975

2014

Link zum Volltext

Verfügbarkeit prüfen

MYD88 mutations identify a molecular subgroup of diffuse large B-cell lymphoma with an unfavorable prognosis

Haematologica (Roma), 2020-02, Vol.105 (2), p.424-434

2020

Link zum Volltext

Verfügbarkeit prüfen

Platelet Transfusion before CVC Placement in Patients with Thrombocytopenia

The New England journal of medicine, 2023-05, Vol.388 (21), p.1956-1965

2023

Link zum Volltext

Verfügbarkeit prüfen

Trastuzumab plus pertuzumab for HER2-amplified advanced colorectal cancer: Results from the drug rediscovery protocol (DRUP)

European journal of cancer (1990), 2024-05, Vol.202, p.113988-113988, Article 113988

2024

Link zum Volltext

Verfügbarkeit prüfen

Treatment strategies and clinical outcomes in consecutive patients with locally advanced pancreatic cancer: A multicenter prospective cohort

European journal of surgical oncology, 2021-03, Vol.47 (3), p.699-707

2021

Link zum Volltext

Verfügbarkeit prüfen

Predictors of the corrected count increment after platelet transfusion, a secondary analysis of the PACER randomized controlled trial

American journal of hematology, 2023-11, Vol.98 (11), p.E305-E308

2023

Link zum Volltext

Verfügbarkeit prüfen

Enzalutamide as a Fourth- or Fifth-Line Treatment Option for Metastatic Castration-Resistant Prostate Cancer

Oncology, 2016-01, Vol.91 (5), p.267-273

2016

Link zum Volltext

Verfügbarkeit prüfen

Sixty-Day Mortality of Patients With Metastatic Colorectal Cancer Randomized to Systemic Treatment vs Primary Tumor Resection Followed by Systemic Treatment: The CAIRO4 Phase 3 Randomized Clinical Trial

JAMA surgery, 2021-12, Vol.156 (12), p.1093

2021

Link zum Volltext

Verfügbarkeit prüfen

First-line systemic treatment strategies in patients with initially unresectable colorectal cancer liver metastases (CAIRO5): an open-label, multicentre, randomised, controlled, phase 3 study from the Dutch Colorectal Cancer Group

The lancet oncology, 2023-07, Vol.24 (7), p.757-771

2023

Link zum Volltext

Verfügbarkeit prüfen

Implementation of Best Practices in Pancreatic Cancer Care in the Netherlands: A Stepped-Wedge Randomized Clinical Trial

JAMA surgery, 2024-04, Vol.159 (4), p.429

2024

Link zum Volltext

Verfügbarkeit prüfen

Survival of patients with deficient mismatch repair metastatic colorectal cancer in the pre-immunotherapy era

British journal of cancer, 2021-01, Vol.124 (2), p.399-406

2021

Link zum Volltext

Verfügbarkeit prüfen

Impact of nationwide implementation of best practices in pancreatic cancer care (PACAP-1): a stepped-wedge cluster randomised controlled trial

Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.], 2023-11, Vol.23, p.e112-e113

2023

Link zum Volltext

Verfügbarkeit prüfen

In situ detection of spontaneous superoxide anion and singlet oxygen production by mitochondria in rat liver and small intestine

Journal of molecular histology, 1997-03, Vol.29 (3), p.229-237

1997

Link zum Volltext

Verfügbarkeit prüfen

1 – 19 von 19

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(19)
Mit Volltextzugriff
(17)

Publikationsform

Artikel
(19)

Sprache

Englisch
(19)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(16)
Science & Technology
(16)
Humans
(13)
Oncology
(10)
Male
(9)
Aged
(7)
Middle Aged
(7)
Female
(5)
Colorectal Cancer
(4)
Patients
(4)
Survival
(4)
Abiraterone
(3)
Antineoplastic Agents - Adverse Effects
(3)
Antineoplastic Agents - Therapeutic Use
(3)
Chemotherapy
(3)
Colorectal Neoplasms - Drug Therapy
(3)
Cross-Resistance
(3)
Disease-Free Survival
(3)
Docetaxel
(3)
Hematology
(3)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Preoperative Chemoradiotherapy Versus Immediate Surgery for Resectable and Borderline Resectable Pancreatic Cancer: Results of the Dutch Randomized Phase III PREOPANC Trial

Neoadjuvant Chemoradiotherapy Versus Upfront Surgery for Resectable and Borderline Resectable Pancreatic Cancer: Long-Term Results of the Dutch Randomized PREOPANC Trial

Clinical activity and tolerability of enzalutamide (MDV3100) in patients with metastatic, castration‐resistant prostate cancer who progress after docetaxel and abiraterone treatment

MYD88 mutations identify a molecular subgroup of diffuse large B-cell lymphoma with an unfavorable prognosis

Platelet Transfusion before CVC Placement in Patients with Thrombocytopenia

Patients with Rare Cancers in the Drug Rediscovery Protocol (DRUP) Benefit from Genomics-Guided Treatment

Trastuzumab plus pertuzumab for HER2-amplified advanced colorectal cancer: Results from the drug rediscovery protocol (DRUP)

Efficacy, safety and biomarker analysis of durvalumab in patients with mismatch-repair deficient or microsatellite instability-high solid tumours

Treatment strategies and clinical outcomes in consecutive patients with locally advanced pancreatic cancer: A multicenter prospective cohort

Predictors of the corrected count increment after platelet transfusion, a secondary analysis of the PACER randomized controlled trial

Prognostic parameters for response to enzalutamide after docetaxel and abiraterone treatment in metastatic castration-resistant prostate cancer patients; a possible time relation

Enzalutamide as a Fourth- or Fifth-Line Treatment Option for Metastatic Castration-Resistant Prostate Cancer

Sixty-Day Mortality of Patients With Metastatic Colorectal Cancer Randomized to Systemic Treatment vs Primary Tumor Resection Followed by Systemic Treatment: The CAIRO4 Phase 3 Randomized Clinical Trial

FOLFOXIRI + bevacizumab versus FOLFOX/FOLFIRI + bevacizumab in patients with initially unresectable colorectal liver metastases (CRLM) and right-sided and/or RAS / BRAFV600E- mutated primary tumor: Phase III CAIRO5 study of the Dutch Colorectal Cancer Group

First-line systemic treatment strategies in patients with initially unresectable colorectal cancer liver metastases (CAIRO5): an open-label, multicentre, randomised, controlled, phase 3 study from the Dutch Colorectal Cancer Group

Implementation of Best Practices in Pancreatic Cancer Care in the Netherlands: A Stepped-Wedge Randomized Clinical Trial

Survival of patients with deficient mismatch repair metastatic colorectal cancer in the pre-immunotherapy era

Impact of nationwide implementation of best practices in pancreatic cancer care (PACAP-1): a stepped-wedge cluster randomised controlled trial

In situ detection of spontaneous superoxide anion and singlet oxygen production by mitochondria in rat liver and small intestine

Suchergebnisse filtern